Status:
UNKNOWN
Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection
Lead Sponsor:
Massachusetts General Hospital
Conditions:
COVID-19
Eligibility:
All Genders
Phase:
NA
Brief Summary
The study will be a prospective cohort design to determine if children generate aerosols that harbor a viral load similar to adults. Prior to beginning enrollment, researchers may recruit up to 10 par...
Detailed Description
For children and adults who are admitted to MGH, study staff will perform: Step 1: A nasal and oral swab will be obtained to establish the nasopharyngeal viral load. Step 2: Study staff will use the...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- SARS-CoV-2 PCR positive in the last fourteen days
- Symptomatic with typical symptoms of COVID-19, including fever, cough, nasal congestion, rhinorrhea, anosmia, ageusia, shortness of breath, chest pain, fatigue, myalgias, or other atypical symptoms with documentation of that symptom OR
- Asymptomatic with laboratory confirmation of cycle threshold value \< 30.
- Exclusion criteria:
- Chronic respiratory disease or neuromuscular condition associated with severely reduced lung function defined as FEV1 or FVC \<50% predicted, or requiring chronic supplemental oxygen or respiratory support
- On current respiratory support via supplemental oxygen, non-invasive ventilation, or invasive mechanical ventilation
Exclusion
Key Trial Info
Start Date :
January 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05195229
Start Date
January 13 2022
End Date
May 1 2022
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114